| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1c88da57ed94819c156a0fad624caa1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18 |
| filingDate |
2012-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c785934d87a9b97483782faea7492e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cade8d7c6bc487036a11f0b1edc21b1 |
| publicationDate |
2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140043784-A |
| titleOfInvention |
Vaccine composition comprising inactivated chikunguniya virus strain |
| abstract |
A vaccine composition has been described for the prevention and treatment of chikunguniya virus infection that can provide immunity to genotype variants of Chikkununya virus. More specifically, the present invention describes nucleotide sequences and translated proteins thereof that can be expressed as virus like particles, in particular for use as vaccine antigens against chikunguniya virus infection. The compositions of the present invention are also protective against genotype variants of chikunguniya virus that can be propagated into suitable vectors of diseases including Aedis albopictus and Aedis aegypti. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018074884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101875055-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180043752-A |
| priorityDate |
2011-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |